Hanson & Doremus Investment Management Pfizer Inc Transaction History

Hanson & Doremus Investment Management

$627 Million
Q3 2024

A detailed history of Hanson & Doremus Investment Management transactions in Pfizer Inc stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 137,713 shares of PFE stock, worth $3.64 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

137,713

Previous 138,165 0.33%

Holding current value

$3.64 Million

Previous $3.87 Million 3.1%

% of portfolio

0.64%

Previous 0.65%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$27.7 - $31.39 $12,520 - $14,188	-452 Reduced 0.33%	137,713 $3.99 Million
Q2 2024 Aug 08, 2024	BUY	$25.26 - $29.6 $158,253 - $185,444	6,265 Added 4.75%	138,165 $3.87 Million
Q1 2024 Apr 22, 2024	BUY	$25.89 - $29.73 $401,735 - $461,320	15,517 Added 13.33%	131,900 $3.66 Million
Q4 2023 Jan 25, 2024	BUY	$26.13 - $33.94 $666,915 - $866,250	25,523 Added 28.09%	116,383 $3.35 Million
Q3 2023 Oct 24, 2023	SELL	$32.09 - $37.51 $29,875 - $34,921	-931 Reduced 1.01%	90,860 $3.01 Million
Q2 2023 Jul 18, 2023	SELL	$36.12 - $41.79 $40,454 - $46,804	-1,120 Reduced 1.21%	91,791 $3.37 Million
Q1 2023 Apr 18, 2023	SELL	$39.39 - $51.28 $660,452 - $859,811	-16,767 Reduced 15.29%	92,911 $3.79 Million
Q4 2022 Jan 18, 2023	BUY	$41.75 - $54.5 $498,244 - $650,403	11,934 Added 12.21%	109,678 $5.62 Million
Q3 2022 Oct 20, 2022	SELL	$43.76 - $53.42 $29,625 - $36,165	-677 Reduced 0.69%	97,744 $4.28 Million
Q2 2022 Jul 19, 2022	SELL	$46.53 - $55.17 $172,393 - $204,404	-3,705 Reduced 3.63%	98,421 $5.16 Million
Q1 2022 Apr 22, 2022	SELL	$45.75 - $56.69 $823 - $1,020	-18 Reduced 0.02%	102,126 $5.29 Million
Q4 2021 Jan 20, 2022	SELL	$41.32 - $61.25 $24,461 - $36,260	-592 Reduced 0.58%	102,144 $6.03 Million
Q3 2021 Oct 21, 2021	SELL	$39.25 - $50.42 $427,707 - $549,426	-10,897 Reduced 9.59%	102,736 $4.42 Million
Q2 2021 Jul 22, 2021	SELL	$35.91 - $40.68 $273,598 - $309,940	-7,619 Reduced 6.28%	113,633 $4.17 Million
Q1 2021 May 03, 2021	SELL	$33.49 - $37.77 $41,527 - $46,834	-1,240 Reduced 1.01%	121,252 $4.39 Million
Q4 2020 Feb 01, 2021	BUY	$33.47 - $42.56 $296,510 - $377,039	8,859 Added 7.8%	122,492 $4.51 Million
Q3 2020 Oct 19, 2020	SELL	$31.75 - $37.25 $64,008 - $75,096	-2,016 Reduced 1.74%	113,633 $4.17 Million
Q2 2020 Jul 17, 2020	SELL	$30.12 - $36.54 $543,846 - $659,766	-18,056 Reduced 13.5%	115,649 $3.78 Million
Q1 2020 Apr 24, 2020	BUY	$27.03 - $38.62 $396,232 - $566,130	14,659 Added 12.31%	133,705 $4.14 Million
Q4 2019 Jan 16, 2020	BUY	$32.92 - $37.36 $65,412 - $74,234	1,987 Added 1.7%	119,046 $4.66 Million
Q3 2019 Oct 18, 2019	BUY	$32.49 - $42.13 $39,670 - $51,440	1,221 Added 1.05%	117,059 $4.21 Million
Q2 2019 Jul 18, 2019	SELL	$36.98 - $41.52 $166,927 - $187,421	-4,514 Reduced 3.75%	115,838 $5.02 Million
Q1 2019 Apr 23, 2019	SELL	$37.5 - $41.2 $79,125 - $86,932	-2,110 Reduced 1.72%	120,352 $0
Q4 2018 Jan 31, 2019	SELL	$38.47 - $43.86 $78,940 - $90,000	-2,052 Reduced 1.65%	122,462 $5.35 Million
Q3 2018 Oct 24, 2018	SELL	$34.47 - $41.81 $49,671 - $60,248	-1,441 Reduced 1.14%	124,514 $0
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $611,779 - $652,217	-18,550 Reduced 12.84%	125,955 $4.57 Million
Q1 2018 May 10, 2018	BUY	$31.91 - $37.02 $413,011 - $479,149	12,943 Added 9.84%	144,505 $5.13 Million
Q4 2017 Jan 25, 2018	BUY	$33.26 - $35.29 $19,689 - $20,891	592 Added 0.45%	131,562 $4.77 Million
Q3 2017 Oct 26, 2017	BUY	$31.0 - $34.15 $4.06 Million - $4.47 Million	130,970	130,970 $0

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hanson & Doremus Investment Management with notifications on news.

Account

Hanson & Doremus Investment Management Pfizer Inc Transaction History